US Pharma MarketingRoivant's autoimmune drug approval, Cytokinetics reports full data for heart condition treatment, and more biotech news research Physicians FDA Newsletters Log In My Account Subscribe Now My Account Settings Complete your personal information for a more tailored experience Billing Log Out Reporting from the frontiers of health and medicine Newsletters Log In My Account Subscribe Now Biotech Pharma Public Health Health Tech Policy Science First Opinion STAT+ STAT Events Search Log In Try STAT+ My Account Home Newsletter The Readout AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching Roivant’s autoimmune drug approval, Cytokinetics reports…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
We have some news out of a meeting of the European Society of Cardiology, Roivant won a key autoimmune drug approval, and former Stanford president Marc Tessier-Lavigne is pushing back against revived allegations of research fraud.
RIP to Yayoi Kusama. Wearing manic polka dots today in tribute.
Source: STAT News Pharma